Mo. firm expected to benefit from Obama policy, stimulus plan

03/12/2009 | St. Louis Post-Dispatch

St. Louis-based Sigma-Aldrich, a provider of scientific kits and products for stem cell research, is one of the firms expected to benefit from the recent lifting of federal funding limits on embryonic stem cell research. The company also is looking to get a boost from the stimulus plan that allotted NIH funding for induced pluripotent stem cell research.

View Full Article in:

St. Louis Post-Dispatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA